Hostname: page-component-68945f75b7-72kh6 Total loading time: 0 Render date: 2024-08-05T18:14:31.646Z Has data issue: false hasContentIssue false
  • English
  • Français

Benefits of citalopram vs viloxazine, both given as an intravenous-to-oral regimen for severe depression

Published online by Cambridge University Press:  16 April 2020

J.M. Bouchard  and
R. Nil
J.M. Bouchard
Affiliation:
C.G.S. Gérard Marchant, Toulouse, France
R. Nil
Affiliation:
H. Lundbeck A/S, Copenhagen, Denmark

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 13 , Issue S4: Standards of psychiatry - 9th Congress of Association of European Psychiatrists , 1998 , pp. 264s
Copyright
Copyright © European Psychiatric Association 1998
Submit a response

Comments

No Comments have been published for this article.